TrkB inhibition as a therapeutic target for CNS-related disorders

Fabien Boulle, Gunter Kenis*, Maxime Cazorla, Michel Hamon, Harry W. M. Steinbusch, Laurence Lanfumey, Daniel L. A. van den Hove

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'TrkB inhibition as a therapeutic target for CNS-related disorders'. Together they form a unique fingerprint.

INIS

Keyphrases

Medicine and Dentistry

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science